EP0707493A4 - Co-localisation d'une molecule cible et de ses inhibiteurs - Google Patents

Co-localisation d'une molecule cible et de ses inhibiteurs

Info

Publication number
EP0707493A4
EP0707493A4 EP95904785A EP95904785A EP0707493A4 EP 0707493 A4 EP0707493 A4 EP 0707493A4 EP 95904785 A EP95904785 A EP 95904785A EP 95904785 A EP95904785 A EP 95904785A EP 0707493 A4 EP0707493 A4 EP 0707493A4
Authority
EP
European Patent Office
Prior art keywords
localization
inhibitors
target molecule
molecule
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95904785A
Other languages
German (de)
English (en)
Other versions
EP0707493A1 (fr
Inventor
John J Rossi
Garry P Larson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
City of Hope
Original Assignee
City of Hope
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/185,827 external-priority patent/US5827935A/en
Application filed by City of Hope filed Critical City of Hope
Publication of EP0707493A1 publication Critical patent/EP0707493A1/fr
Publication of EP0707493A4 publication Critical patent/EP0707493A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP95904785A 1994-01-24 1994-12-02 Co-localisation d'une molecule cible et de ses inhibiteurs Withdrawn EP0707493A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/185,827 US5827935A (en) 1992-05-27 1992-05-27 Chimeric tRNAlys -ribozyme molecules
US185827 1994-01-24
PCT/US1994/013798 WO1995019788A1 (fr) 1994-01-24 1994-12-02 Co-localisation d'une molecule cible et de ses inhibiteurs

Publications (2)

Publication Number Publication Date
EP0707493A1 EP0707493A1 (fr) 1996-04-24
EP0707493A4 true EP0707493A4 (fr) 1999-03-31

Family

ID=22682602

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95904785A Withdrawn EP0707493A4 (fr) 1994-01-24 1994-12-02 Co-localisation d'une molecule cible et de ses inhibiteurs

Country Status (4)

Country Link
EP (1) EP0707493A4 (fr)
AU (1) AU692208B2 (fr)
CA (1) CA2157015A1 (fr)
WO (1) WO1995019788A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7919583B2 (en) 2005-08-08 2011-04-05 Discovery Genomics, Inc. Integration-site directed vector systems
WO2010008562A2 (fr) 2008-07-16 2010-01-21 Recombinetics Procédés et matériaux pour produire des animaux transgéniques

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0387775A1 (fr) * 1989-03-16 1990-09-19 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Unité génétique pour inhiber la fonction d'ARN
WO1993023569A1 (fr) * 1992-05-11 1993-11-25 Ribozyme Pharmaceuticals, Inc. Procede et reactif d'inhibition de la replication virale
WO1993024133A1 (fr) * 1992-05-27 1993-12-09 City Of Hope MOLECULES CHIMERIQUES DE RIBOZYMES D'ARNt?LYS¿

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0387775A1 (fr) * 1989-03-16 1990-09-19 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Unité génétique pour inhiber la fonction d'ARN
WO1993023569A1 (fr) * 1992-05-11 1993-11-25 Ribozyme Pharmaceuticals, Inc. Procede et reactif d'inhibition de la replication virale
WO1993024133A1 (fr) * 1992-05-27 1993-12-09 City Of Hope MOLECULES CHIMERIQUES DE RIBOZYMES D'ARNt?LYS¿

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HERSCHLAG D ET AL: "AN RNA CHAPERONE ACTIVITY OF NON-SPECIFIC RNA BINDING PROTEINS IN HAMMERHEAD RIBOZYME CATALYSIS", EMBO JOURNAL, vol. 13, no. 12, 15 June 1994 (1994-06-15), pages 2913 - 2924, XP000567895 *
ROSSI J J ET AL: "RIBOZYMES AS ANTI-HIV-1 THERAPEUTIC AGENTS: PRINCIPLES, APPLICATIONS, AND PROBLEMS", AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 8, no. 2, February 1992 (1992-02-01), pages 183 - 189, XP002026934 *
See also references of WO9519788A1 *
SULLENGER B A ET AL: "TETHERING RIBOZYMES TO A RETROVIRAL PACKAGING SIGNAL FOR DESTRUCTION OF VIRAL RNA", SCIENCE, vol. 262, 3 December 1993 (1993-12-03), pages 1566 - 1569, XP000567869 *

Also Published As

Publication number Publication date
AU692208B2 (en) 1998-06-04
CA2157015A1 (fr) 1995-07-27
AU1333595A (en) 1995-08-08
WO1995019788A1 (fr) 1995-07-27
EP0707493A1 (fr) 1996-04-24

Similar Documents

Publication Publication Date Title
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
EP0835109A4 (fr) Inhibiteurs de la thrombine a base de pyridinone
ZA98376B (en) Sulfamide-metalloprotease inhibitors
PL331900A1 (en) 1,4-heterocyclic inhibitors of metaloprotease
PL331838A1 (en) 1,3-diheterocyclic inhibitors of metaloproteases
PL330120A1 (en) Farnesilic protein transferase inhibitors
GB9611422D0 (en) Coated scale inhibitors
GB2321641B (en) Sulfamide-metalloprotease inhibitors
GB9623908D0 (en) Amino acid derivatives
IL129561A0 (en) N-substituted 2-cyanopyrrolidines
PL331795A1 (en) Heterocyclic metaloprotease inhibitors
PL330482A1 (en) Novel amino acid derivatives and their application as thrombosin inhibitors
PL328074A1 (en) Therapeutical method and pharmaceutic composition
PL331803A1 (en) Bidonoric metaloprotease inhibitors
HUP9903631A3 (en) Adhesion inhibitors
GB9422952D0 (en) Corrosion inhibitor
ZA988934B (en) Method and composition for inhibiting corrosion
GB9425701D0 (en) Enzyme inhibitors
GB2319530B (en) Low toxic corrosion inhibitor
HU9503783D0 (en) Squvalen syntetase inhibitors
ZA9711548B (en) Ricin inhibitors and methods for use thereof
DE69523450D1 (en) Inhibitor
EP0707493A4 (fr) Co-localisation d'une molecule cible et de ses inhibiteurs
GB9321917D0 (en) Corrosion inhibitors
GB9311043D0 (en) Inhibitors of nef-cd4 binding

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950913

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB

A4 Supplementary search report drawn up and despatched

Effective date: 19990215

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE FR GB

17Q First examination report despatched

Effective date: 20000524

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20001205